Intensive Longitudinal Study of Fear of Recurrence in Cancer Patients and Spouses

癌症患者及其配偶对复发的恐惧的深入纵向研究

基本信息

  • 批准号:
    8533703
  • 负责人:
  • 金额:
    $ 21.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-03-15 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Breast cancer is the most common cancer in women across the US as well as developed and developing regions across the world. There are over 10 million Americans who live with a personal history of cancer and are thus considered to be cancer survivors. Among survivors, fear of cancer recurrence (FOR) is the most prevalent psychosocial concern and can be more pronounced for partners and caregivers than for the patients themselves. Despite substantial anecdotal, clinical, and cross-sectional evidence, at present there is surprisingly little known empirically about the temporal course of FOR or the factors that predict prospectively who will suffer from chronic and/or severe FOR. The behavioral research proposed in this R21 application will be the first comprehensive and intensive investigation into the everyday as well as longer-term predictors of FOR in the lives of BC survivors and their spouses/partners. This work has important implications for clinical practice guidelines for the psychosocial care of BC survivors (both patient and their significant others) including effective psychosocial-focused assessment, intervention services, and cancer survivorship programming. The proposed work represents the next step in an ongoing collaboration between behavioral science researchers at the University of Delaware and Helen F. Graham Cancer Center (an NCI-designated Community Cancer Center part of Christiana Care Health System, Newark, DE).
描述(由申请人提供):乳腺癌是美国以及世界上发达和发展中地区女性最常见的癌症。有超过1000万美国人生活在癌症的个人历史中,因此被认为是癌症幸存者。在幸存者中,对癌症复发的恐惧(FOR)是最普遍的心理社会问题,对伴侣和照顾者的恐惧可能比患者本身更明显。尽管有大量的轶事,临床和横断面证据,目前令人惊讶的是,很少有人知道经验的时间过程中的FOR或因素,预测谁将遭受慢性和/或严重的FOR。R21申请中提出的行为研究将是对BC幸存者及其配偶/伴侣生活中FOR的日常和长期预测因素的第一次全面深入的调查。这项工作具有重要意义的临床实践指南BC幸存者(患者和他们的重要他人)的心理社会护理,包括有效的心理社会为重点的评估,干预服务,和癌症生存规划。这项工作代表了特拉华州的行为科学研究人员和海伦F。格雷厄姆癌症中心(NCI-designated Community Cancer Center part of Christiana Care Health System,纽瓦克,DE)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jean-Philippe Laurenceau其他文献

Jean-Philippe Laurenceau的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jean-Philippe Laurenceau', 18)}}的其他基金

Health Consequences of Fear of Cancer Recurrence in Breast Cancer Survivors and Partners
乳腺癌幸存者和伴侣担心癌症复发的健康后果
  • 批准号:
    9974152
  • 财政年份:
    2020
  • 资助金额:
    $ 21.65万
  • 项目类别:
Health Consequences of Fear of Cancer Recurrence in Breast Cancer Survivors and Partners
乳腺癌幸存者和伴侣担心癌症复发的健康后果
  • 批准号:
    10378516
  • 财政年份:
    2020
  • 资助金额:
    $ 21.65万
  • 项目类别:
Intensive Longitudinal Study of Fear of Recurrence in Cancer Patients and Spouses
癌症患者及其配偶对复发的恐惧的深入纵向研究
  • 批准号:
    8637942
  • 财政年份:
    2013
  • 资助金额:
    $ 21.65万
  • 项目类别:
Personality and Daily Relationship Processes
性格和日常关系过程
  • 批准号:
    6542713
  • 财政年份:
    2002
  • 资助金额:
    $ 21.65万
  • 项目类别:
Personality and Daily Relationship Processes
性格和日常关系过程
  • 批准号:
    6931234
  • 财政年份:
    2002
  • 资助金额:
    $ 21.65万
  • 项目类别:
Personality and Daily Relationship Processes
性格和日常关系过程
  • 批准号:
    6778337
  • 财政年份:
    2002
  • 资助金额:
    $ 21.65万
  • 项目类别:
Personality and Daily Relationship Processes
性格和日常关系过程
  • 批准号:
    7121128
  • 财政年份:
    2002
  • 资助金额:
    $ 21.65万
  • 项目类别:
Personality and Daily Relationship Processes
性格和日常关系过程
  • 批准号:
    6643454
  • 财政年份:
    2002
  • 资助金额:
    $ 21.65万
  • 项目类别:
INTIMACY PROCESSES IN MARRIAGE--A DAILY DIARY APPROACH
婚姻中的亲密过程——每日日记法
  • 批准号:
    2523201
  • 财政年份:
    1998
  • 资助金额:
    $ 21.65万
  • 项目类别:

相似海外基金

Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
  • 批准号:
    23K08213
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
  • 批准号:
    2881726
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
    Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
  • 批准号:
    10722146
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
  • 批准号:
    10935776
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
  • 批准号:
    10935796
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
  • 批准号:
    10935775
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
  • 批准号:
    10649041
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
  • 批准号:
    10735964
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了